|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 05, 2015 ) Dallas, TX -- The North America intrauterine contraceptive devices market has been categorized, on the basis of type, into hormonal IUCD and copper IUCD. The hormonal IUCD segment contributed the larger share of 83.4% in 2014 to the total market value of intrauterine contraceptive devices, followed by the copper IUCD segment with 16.6% market share. On the basis of products, this market has been segmented as Mirena, Skyla, ParaGuard, and Essure. The major countries covered in this report for a comprehensive analysis of the concerned market include the U.S. and Canada.
The growth of the intrauterine contraceptive devices market is driven by various factors, such as the rising rate of unplanned pregnancies, effective contraception and minimum side effects of IUCD, implementation of the Affordable Care Act (ACA), higher number of initiatives undertaken by private firms directed towards reducing the expenses related to abortion, and the various technological advancements. For instance, the Colorado Family Planning Initiative has provided more than 30,000 intrauterine devices (IUCDs) or implants at low or no cost to low-income women at 68 family planning clinics across Colorado, since 2009.
Complete report available @ http://www.reportsnreports.com/reports/319515-north-america-intrauterine-contraceptive-devices-market.html .
The decline in births among young women, served by these agencies, accounted for three-quarters of the overall decline in the Colorado teen birth rate. As a result, in July 2014, the organization announced that, the teen birth rate in Colorado dropped by 40% from 2009 to 2013, driven by a Colorado Department of Public Health and Environment initiative that helps low-income women get long-acting reversible contraceptives (LARC), such as intrauterine contraceptive devices. High costs of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, and high rate of complications during unplanned pregnancy are among the main factors hindering the growth of the IUCD market. The report also provides a detailed competitive landscaping of the major companies operating in this market.
Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this research report. The main companies operating in the North American market are Bayer HealthCare AG (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland), among others
Purchase a copy of this report @ http://www.reportsnreports.com/purchase.aspx?name=319515 .
Table of Content
1 Introduction
2 Research Methodology
3 Executive Summary
4 Market Overview
5 North America Intra-Uterine Contraceptive Devices Market, by Type
6 North America Intra-Uterine Contraceptive Devices Market, by Product
7 North America Intra-Uterine Contraceptive Devices Market, by Geography
8 North America Intra-Uterine Contraceptive Devices Market: Competitive Landscape
9 North America Intra-Uterine Contraceptive Devices Market, by Company
10 Appendix
Discount for this report - http://www.reportsnreports.com/contacts/discount.aspx?name=319515 .
US$ 2650 (Single User License)
About Us
ReportsnReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
ReportsnReports
Siju K.
+ 18883915441
sales@reportsandreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
